Compare XRAY & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XRAY | GENB |
|---|---|---|
| Founded | 1899 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2009 | 2026 |
| Metric | XRAY | GENB |
|---|---|---|
| Price | $9.31 | $12.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 6 |
| Target Price | $11.03 | ★ $27.00 |
| AVG Volume (30 Days) | ★ 4.9M | 901.7K |
| Earning Date | 11-05-2026 | 11-24-2026 |
| Dividend Yield | ★ 1.64% | N/A |
| EPS Growth | ★ 33.04 | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.64 | N/A |
| P/E Ratio | $81.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.14 | $11.00 |
| 52 Week High | $14.76 | $22.67 |
| Indicator | XRAY | GENB |
|---|---|---|
| Relative Strength Index (RSI) | 47.99 | 43.75 |
| Support Level | $8.32 | $11.93 |
| Resistance Level | $10.71 | $14.29 |
| Average True Range (ATR) | 0.51 | 1.16 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 46.53 | 21.77 |
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.